查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1457951

全球外科手术市场：市场规模和占有率分析（依类型、提供者、性别和年龄层）、行业需求预测（截至 2030 年）

Surgical Procedures Market Size and Share Analysis by Type, Provider, Gender, Age Group - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球外科手术市场正以 3.3% 的复合年增长率扩张，到 2023 年将达到 1.1 亿例，到 2030 年将达到 1.375 亿例。

造成此现象的主要原因是慢性病，特别是癌症和心血管疾病的发生率迅速上升，加上人口老化。

北美引领市场

2023 年，北美市占率最大，达 50%。 这是由于发达的医疗保健系统的存在，以及心臟病、骨科疾病和胃肠道疾病等疾病盛行率的增加。

亚太地区未来几年将以最快的速度成长，约3.5%。 这是由于人们对慢性病的认识不断提高、外科技术的发展、神经系统疾病和创伤发病率的增加以及医疗和医疗旅游部门的兴起。

依细分市场的见解

2023年，妇产科品类比最大，占约30%。 这是由于多囊性卵巢症候群（PCOS）、子宫内膜异位症、卵巢囊肿、慢性骨盆腔疼痛、卵巢和子宫癌、骨盆腔发炎、子宫肌瘤、子宫肌腺症等妇科疾病的发生率不断增加所致。

另一方面，眼科领域预计未来几年将以最快约3.7%的速度发展。 这主要是由于青光眼、糖尿病视网膜病变、白内障等各种眼部疾病的发生率不断增加。

到 2023 年，医院将成为最大的最终用户类别，约占 45% 的占有率，并将在这十年中保持最大的地位。 这是由于全世界这些医疗机构进行的手术数量庞大以及各种慢性病的盛行率不断增加。

本报告分析了全球外科市场，包括市场的基本结构和最新情况、主要促进和限制因素以及全球、依地区和主要国家的市场规模前景（病例数、金额（2017-2030）、依类型、提供者、性别和年龄组别划分的详细趋势、市场竞争现状以及主要公司概况。

目录

第一章研究范围

第二章研究方法

第 3 章执行摘要

第 4 章市场指标

第五章产业展望

  • 市场动态
    • 趋势
    • 促进因素
    • 抑制因素/课题
    • 促进/抑制因子影响分析
  • 新型冠状病毒感染 (COVID-19) 的影响
  • 波特五力分析

第六章世界市场

  • 摘要
  • 市场规模：依类型划分（2017-2030 年）
  • 市场收入：依类型划分（2017-2030 年）
  • 市场规模：依供应商划分（2017-2030 年）
  • 市场收入：依提供者划分（2017-2030 年）
  • 市场规模：依性别划分（2017-2030 年）
  • 市场收入：依性别划分（2017-2030 年）
  • 市场规模：依年龄层划分（2017-2030 年）
  • 市场收入：依年龄层划分（2017-2030 年）
  • 市场规模：依地区划分（2017-2030 年）
  • 市场收入：依地区划分（2017-2030 年）

第七章北美市场

  • 摘要
  • 市场规模：依类型划分（2017-2030 年）
  • 市场收入：依类型划分（2017-2030 年）
  • 市场规模：依供应商划分（2017-2030 年）
  • 市场收入：依提供者划分（2017-2030 年）
  • 市场规模：依性别划分（2017-2030 年）
  • 市场收入：依性别划分（2017-2030 年）
  • 市场规模：依年龄层划分（2017-2030 年）
  • 市场收入：依年龄层划分（2017-2030 年）
  • 市场规模：依国家划分（2017-2030 年）
  • 市场收入：依国家/地区划分（2017-2030 年）

第8章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第 11 章中东与非洲 (MEA) 市场

第12章美国市场

  • 摘要
  • 市场规模：依类型划分（2017-2030 年）
  • 市场收入：依类型划分（2017-2030 年）
  • 市场规模：依供应商划分（2017-2030 年）
  • 市场收入：依提供者划分（2017-2030 年）
  • 市场规模：依性别划分（2017-2030 年）
  • 市场收入：依性别划分（2017-2030 年）
  • 市场规模：依年龄层划分（2017-2030 年）
  • 市场收入：依年龄层划分（2017-2030 年）

第十三章加拿大市场

第14章德国市场

第十五章法国市场

第十六章英国市场

第十七章义大利市场

第十八章西班牙市场

第十九章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

  • 市场参与者及其提供的产品/服务的列表
  • 主要公司的竞争基准
  • 各大公司的产品基准
  • 近期策略发展状况

第30章公司简介

  • Stryker Corporation
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Zimmer Biomet
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Smith & Nephew
  • Medtronic plc
  • Cook Medical
  • CONMED Corporation

第31章附录

简介目录
Product Code: 12799

The surgical procedures market was 110.0 million procedures in 2023, and it will increase to 137.5 million, advancing at a 3.3% compound annual growth rate, by 2030.

This is mainly because of the surging incidence of chronic disorders, particularly cancer and CVDs; coupled with the increasing elderly population.

Aging people are more vulnerable to chronic ailments like diabetes, cancer, cardiovascular diseases, and neurological disorders, which led to the growing need for surgical procedures. Likewise, the low levels of immunity make the elderly population more susceptible to infections, therefore resulting in an increase in the number of surgical procedures.

As per the World Health Organization, there were an estimated 20 million new cases of cancer and 9.7 million deaths in 2022.

The projected number of individuals who were alive within 5 years following a cancer diagnosis was 53.5 million.

Approximately 1 out of 5 people develop cancer in their lifetime, around 1 out of 12 women and 1 out of 9 men die from the ailment.

Moreover, as per a report, worldwide death counts because of CVD increase to 19.8 million in 2022 from 12.4 million in 1990 reflecting worldwide population growth as well as aging.

Furthermore, the technological improvements in the surgical process will further assist the growth of this industry in the years to come.

The high count of outpatient surgeries is offering significant growth opportunities to the industry. Outpatient surgeries do not mandate an overnight stay at the hospital. Currently, medical procedures are increasing at outpatient facilities due to technological improvements, counting the arrival of minimally invasive surgeries, and the accessibility of value-based care incentives.

North America is Leading Market

North America accounted for the largest share of the industry in 2023, of 50%. This is because of the existence of developed healthcare systems, along with the rising incidence of diseases like cardiac, orthopedic, and gastrointestinal disorders.

Moreover, the higher acceptance rate of cutting-edge devices as well as the change in the fondness toward outpatient surgeries are also aiding the regional industry growth.

APAC will advance at the fastest rate of approximately 3.5% in the coming years. This is because of the rising consciousness of chronic disorders, the arrival of developed surgical technologies, the increasing incidence of neurological disorders and traumatic injuries, and the flourishing healthcare and medical tourism sectors, in this region.

Segmentation Insights

The obstetric & gynecological category was the largest contributor to the industry in 2023, with approximately 30% share. This is ascribed to the increasing incidence of gynecological disorders, including polycystic ovary syndrome (PCOS), endometriosis, ovarian cysts, chronic pelvic pain, ovarian and uterine cancer, pelvic inflammatory disease, uterine fibroids, and adenomyosis.

Whereas, the ophthalmic category will advance at the fastest rate, of approximately 3.7%, in the years to come. This can be mainly because of the increasing occurrence of various ophthalmic disorders, such as glaucoma, diabetic retinopathy, and cataracts.

The hospital was the largest end user category in 2023, with approximately 45% share, and it will remain the largest throughout this decade. This is because of the high count of surgeries carried out in these healthcare settings globally; and the rising prevalence of various chronic ailments.

With the surging occurrence of chronic diseases across the globe, the need for surgical procedures will continue to increase in the years to come.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by provider
    • 1.4.3. Market size breakdown, by gender
    • 1.4.4. Market size breakdown, by age group
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Provider (2017-2030)
  • 6.5. Market Revenue, by Provider (2017-2030)
  • 6.6. Market Volume, by Gender (2017-2030)
  • 6.7. Market Revenue, by Gender (2017-2030)
  • 6.8. Market Volume, by Age Group (2017-2030)
  • 6.9. Market Revenue, by Age Group (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Provider (2017-2030)
  • 7.5. Market Revenue, by Provider (2017-2030)
  • 7.6. Market Volume, by Gender (2017-2030)
  • 7.7. Market Revenue, by Gender (2017-2030)
  • 7.8. Market Volume, by Age Group (2017-2030)
  • 7.9. Market Revenue, by Age Group (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Provider (2017-2030)
  • 8.5. Market Revenue, by Provider (2017-2030)
  • 8.6. Market Volume, by Gender (2017-2030)
  • 8.7. Market Revenue, by Gender (2017-2030)
  • 8.8. Market Volume, by Age Group (2017-2030)
  • 8.9. Market Revenue, by Age Group (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Provider (2017-2030)
  • 9.5. Market Revenue, by Provider (2017-2030)
  • 9.6. Market Volume, by Gender (2017-2030)
  • 9.7. Market Revenue, by Gender (2017-2030)
  • 9.8. Market Volume, by Age Group (2017-2030)
  • 9.9. Market Revenue, by Age Group (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Provider (2017-2030)
  • 10.5. Market Revenue, by Provider (2017-2030)
  • 10.6. Market Volume, by Gender (2017-2030)
  • 10.7. Market Revenue, by Gender (2017-2030)
  • 10.8. Market Volume, by Age Group (2017-2030)
  • 10.9. Market Revenue, by Age Group (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Provider (2017-2030)
  • 11.5. Market Revenue, by Provider (2017-2030)
  • 11.6. Market Volume, by Gender (2017-2030)
  • 11.7. Market Revenue, by Gender (2017-2030)
  • 11.8. Market Volume, by Age Group (2017-2030)
  • 11.9. Market Revenue, by Age Group (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Provider (2017-2030)
  • 12.5. Market Revenue, by Provider (2017-2030)
  • 12.6. Market Volume, by Gender (2017-2030)
  • 12.7. Market Revenue, by Gender (2017-2030)
  • 12.8. Market Volume, by Age Group (2017-2030)
  • 12.9. Market Revenue, by Age Group (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Provider (2017-2030)
  • 13.5. Market Revenue, by Provider (2017-2030)
  • 13.6. Market Volume, by Gender (2017-2030)
  • 13.7. Market Revenue, by Gender (2017-2030)
  • 13.8. Market Volume, by Age Group (2017-2030)
  • 13.9. Market Revenue, by Age Group (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Provider (2017-2030)
  • 14.5. Market Revenue, by Provider (2017-2030)
  • 14.6. Market Volume, by Gender (2017-2030)
  • 14.7. Market Revenue, by Gender (2017-2030)
  • 14.8. Market Volume, by Age Group (2017-2030)
  • 14.9. Market Revenue, by Age Group (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Provider (2017-2030)
  • 15.5. Market Revenue, by Provider (2017-2030)
  • 15.6. Market Volume, by Gender (2017-2030)
  • 15.7. Market Revenue, by Gender (2017-2030)
  • 15.8. Market Volume, by Age Group (2017-2030)
  • 15.9. Market Revenue, by Age Group (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Provider (2017-2030)
  • 16.5. Market Revenue, by Provider (2017-2030)
  • 16.6. Market Volume, by Gender (2017-2030)
  • 16.7. Market Revenue, by Gender (2017-2030)
  • 16.8. Market Volume, by Age Group (2017-2030)
  • 16.9. Market Revenue, by Age Group (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Provider (2017-2030)
  • 17.5. Market Revenue, by Provider (2017-2030)
  • 17.6. Market Volume, by Gender (2017-2030)
  • 17.7. Market Revenue, by Gender (2017-2030)
  • 17.8. Market Volume, by Age Group (2017-2030)
  • 17.9. Market Revenue, by Age Group (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Provider (2017-2030)
  • 18.5. Market Revenue, by Provider (2017-2030)
  • 18.6. Market Volume, by Gender (2017-2030)
  • 18.7. Market Revenue, by Gender (2017-2030)
  • 18.8. Market Volume, by Age Group (2017-2030)
  • 18.9. Market Revenue, by Age Group (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Provider (2017-2030)
  • 19.5. Market Revenue, by Provider (2017-2030)
  • 19.6. Market Volume, by Gender (2017-2030)
  • 19.7. Market Revenue, by Gender (2017-2030)
  • 19.8. Market Volume, by Age Group (2017-2030)
  • 19.9. Market Revenue, by Age Group (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Provider (2017-2030)
  • 20.5. Market Revenue, by Provider (2017-2030)
  • 20.6. Market Volume, by Gender (2017-2030)
  • 20.7. Market Revenue, by Gender (2017-2030)
  • 20.8. Market Volume, by Age Group (2017-2030)
  • 20.9. Market Revenue, by Age Group (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Provider (2017-2030)
  • 21.5. Market Revenue, by Provider (2017-2030)
  • 21.6. Market Volume, by Gender (2017-2030)
  • 21.7. Market Revenue, by Gender (2017-2030)
  • 21.8. Market Volume, by Age Group (2017-2030)
  • 21.9. Market Revenue, by Age Group (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Provider (2017-2030)
  • 22.5. Market Revenue, by Provider (2017-2030)
  • 22.6. Market Volume, by Gender (2017-2030)
  • 22.7. Market Revenue, by Gender (2017-2030)
  • 22.8. Market Volume, by Age Group (2017-2030)
  • 22.9. Market Revenue, by Age Group (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Provider (2017-2030)
  • 23.5. Market Revenue, by Provider (2017-2030)
  • 23.6. Market Volume, by Gender (2017-2030)
  • 23.7. Market Revenue, by Gender (2017-2030)
  • 23.8. Market Volume, by Age Group (2017-2030)
  • 23.9. Market Revenue, by Age Group (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Provider (2017-2030)
  • 24.5. Market Revenue, by Provider (2017-2030)
  • 24.6. Market Volume, by Gender (2017-2030)
  • 24.7. Market Revenue, by Gender (2017-2030)
  • 24.8. Market Volume, by Age Group (2017-2030)
  • 24.9. Market Revenue, by Age Group (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Provider (2017-2030)
  • 25.5. Market Revenue, by Provider (2017-2030)
  • 25.6. Market Volume, by Gender (2017-2030)
  • 25.7. Market Revenue, by Gender (2017-2030)
  • 25.8. Market Volume, by Age Group (2017-2030)
  • 25.9. Market Revenue, by Age Group (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Provider (2017-2030)
  • 26.5. Market Revenue, by Provider (2017-2030)
  • 26.6. Market Volume, by Gender (2017-2030)
  • 26.7. Market Revenue, by Gender (2017-2030)
  • 26.8. Market Volume, by Age Group (2017-2030)
  • 26.9. Market Revenue, by Age Group (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Provider (2017-2030)
  • 27.5. Market Revenue, by Provider (2017-2030)
  • 27.6. Market Volume, by Gender (2017-2030)
  • 27.7. Market Revenue, by Gender (2017-2030)
  • 27.8. Market Volume, by Age Group (2017-2030)
  • 27.9. Market Revenue, by Age Group (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Provider (2017-2030)
  • 28.5. Market Revenue, by Provider (2017-2030)
  • 28.6. Market Volume, by Gender (2017-2030)
  • 28.7. Market Revenue, by Gender (2017-2030)
  • 28.8. Market Volume, by Age Group (2017-2030)
  • 28.9. Market Revenue, by Age Group (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Stryker Corporation
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Becton, Dickinson and Company
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Olympus Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Zimmer Biomet
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Abbott Laboratories
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Boston Scientific Corporation
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Smith & Nephew
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Medtronic plc
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cook Medical
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. CONMED Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports